Madhava Mankal - Medical Innovation CFO and Director
Director
Mr. Madhava Rao Mankal is Chief Financial Officer Director of Medina International Holdings Inc.Mr. Mankal has more than 30 years of experience as an executive. He served as President and the Chief Financial Officer of Force Protection Inc. from May 1999 to December 2003. He served as a director of Force Protection Inc. until September 30 2004. He has over 25 years of senior financial management experience including the positions of controller chief financial officer and financial advisor
Age | 61 |
Phone | 866-883-3793 |
Web | http://medicalinnovationholdings.com |
Similar Executives
Showing other executives | DIRECTOR Age | ||
Edward Frank | Analog Devices | 61 | |
Gregory Dougherty | IPG Photonics | 58 | |
Kelley StevenWaiss | FormFactor | 49 | |
Gary Holman | Awilco Drilling PLC | N/A | |
Karen Golz | Analog Devices | 63 | |
Neil Novich | Analog Devices | 63 | |
Lothar Maier | FormFactor | 63 | |
Ashley Almanza | Noble Plc | 53 | |
Michael Child | IPG Photonics | 62 | |
John Hodgson | Analog Devices | 71 | |
Edward Rogas | FormFactor | 77 | |
Yves Istel | Analog Devices | 79 | |
Eric Meurice | IPG Photonics | 62 | |
Scott Josey | Noble Plc | 62 | |
Ali Husain | Analog Devices | N/A | |
Edmund Stuart | Orbit Garant Drilling | N/A | |
Anantha Chandrakasan | Analog Devices | 49 | |
Raymond Link | FormFactor | 64 | |
William Hurley | IPG Photonics | 71 | |
Bruce Evans | Analog Devices | 58 | |
Kenton Sicchitano | Analog Devices | 73 |
Medical Innovation Leadership Team
Elected by the shareholders, the Medical Innovation's board of directors comprises two types of representatives: Medical Innovation inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medical. The board's role is to monitor Medical Innovation's management team and ensure that shareholders' interests are well served. Medical Innovation's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medical Innovation's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Stol, Director | ||
Redgie Green, Director | ||
Arturo Sanchez, CEO | ||
Bart Siegel, Director | ||
Raymond Demotte, CFO, Director | ||
Lawrence Litowitz, Interim CFO | ||
Madhava Mankal, CFO and Director | ||
Daniel Medina, CEO and President and Director | ||
John Lewis, Director | ||
Raimundo Dias, President Corporate Secretary, Director | ||
Michael Gallo, Director |
Medical Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc bb equity is not an easy task. Is Medical Innovation a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Current Valuation | 567.7 K | |||
Shares Outstanding | 39.88 M | |||
Shares Owned By Insiders | 0.20 % | |||
Price To Earning | (22.61) X | |||
Price To Sales | 4.15 X | |||
Revenue | 48 K | |||
Net Income | (1.43 M) | |||
Cash And Equivalents | 6.46 K | |||
Total Debt | 514.34 K | |||
Book Value Per Share | (0.04) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medical Innovation in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medical Innovation's short interest history, or implied volatility extrapolated from Medical Innovation options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Medical Innovation information on this page should be used as a complementary analysis to other Medical Innovation's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Medical OTC BB Equity
If you are still planning to invest in Medical Innovation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medical Innovation's history and understand the potential risks before investing.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |